Micromem Applied Sensor Technologies

Micromem Applied Sensor Technologies (MAST) is a subsidiary of Micromem Technologies Inc., specializing in the development of advanced sensor solutions using proprietary nanotechnology. The company focuses on creating high-sensitivity sensors for various industries, with a significant emphasis on healthcare and medical diagnostics. MAST has developed a liquid-phase nanowire bio-chemical sensor platform capable of detecting disease-associated biomarkers, such as TREM-1, at picomolar concentrations. This technology is designed for early-stage disease monitoring and point-of-care diagnostics, offering a cost-effective and scalable solution for identifying inflammatory and pathological markers. The company operates as a pre-revenue entity, primarily funding its research and development through strategic collaborations and private placements. MAST continues to advance its sensor intellectual property through partnerships with institutions like the University of Toronto and the Canadian Department of National Defence.